Comparative analysis of cognitive impairment prevalence and its etiological subtypes in a rural area of northern China between 2010 and 2015.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 01 2019
Historique:
received: 09 08 2017
accepted: 03 12 2018
entrez: 31 1 2019
pubmed: 31 1 2019
medline: 5 9 2020
Statut: epublish

Résumé

The purpose of this study was to evaluate changes in the prevalence and risk factors of cognitive impairment (CI) by analyzing and comparing two cross-sectional epidemiological surveys of CI and its subtypes were performed in a rural area of northern China between 2010 and 2015. Residents aged ≥60 years were drawn in northern China. The Mini Mental State Examination (MMSE) is recommended to test for CI. Dementia was further categorised into Alzheimer's disease (AD), vascular dementia (VaD), and dementia caused by other diseases (ODs). Mild cognitive impairment (MCI) was classified into MCI caused by AD (MCI-A), MCI caused by VaD (MCI-VD), and MCI caused by ODs (MCI-O). The prevalence of CI increased in China. The prevalence of all-cause CI was 30·5% (22.9% MCI and 7.6% dementia) in 2010. The prevalence of all-cause CI was 38.3% (27.8% MCI and 10.5% dementia) in 2015. Similar increases were observed for the prevalence of subtypes of dementia and MCI. These findings suggest an increasing prevalence of CI and its subtypes in China, which may be related to alterations in sociodemographic factors, vascular risk factors and lifestyle changes over time in these cohorts.

Identifiants

pubmed: 30696930
doi: 10.1038/s41598-018-37286-z
pii: 10.1038/s41598-018-37286-z
pmc: PMC6351643
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

851

Subventions

Organisme : NIA NIH HHS
ID : P30 AG008051
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS073502
Pays : United States

Références

Neurology. 2000;54(11 Suppl 5):S4-9
pubmed: 10854354
Stroke. 2000 Jul;31(7):1487-93
pubmed: 10884442
Am J Epidemiol. 2000 Jul 1;152(1):59-66
pubmed: 10901330
Toxicology. 2000 Nov 16;153(1-3):167-78
pubmed: 11090955
Am J Epidemiol. 2001 Jan 15;153(2):137-44
pubmed: 11159158
Arch Neurol. 2001 Mar;58(3):397-405
pubmed: 11255443
Neurology. 2002 Apr 23;58(8):1175-81
pubmed: 11971083
Ann Intern Med. 2002 Aug 6;137(3):149-55
pubmed: 12160362
Biomed Pharmacother. 2004 Mar;58(2):95-9
pubmed: 14992790
Arch Neurol. 2005 Mar;62(3):447-53
pubmed: 15767510
Eur Neuropsychopharmacol. 2005 Aug;15(4):463-71
pubmed: 15955676
Lancet. 2005 Dec 17;366(9503):2112-7
pubmed: 16360788
J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):308-16
pubmed: 16484637
Lancet. 2006 Apr 15;367(9518):1262-70
pubmed: 16631882
Acta Psychiatr Scand. 2007 Jan;115(1):73-9
pubmed: 17201869
Ann Neurol. 1991 Dec;30(6):817-24
pubmed: 1838681
Vasc Health Risk Manag. 2008;4(2):395-402
pubmed: 18561514
Lancet. 2009 Nov 28;374(9704):1821-30
pubmed: 19944863
Dement Geriatr Cogn Disord. 2010;30(3):277-84
pubmed: 20847559
Arch Intern Med. 2011 Feb 28;171(4):333-9
pubmed: 20975015
Alzheimers Dement. 2011 Jan;7(1):61-73
pubmed: 21255744
Alzheimers Dement. 2011 Jan;7(1):80-93
pubmed: 21255746
Dialogues Clin Neurosci. 2004 Dec;6(4):401-8
pubmed: 22034212
Lancet. 2012 Jul 7;380(9836):50-8
pubmed: 22626851
Lancet. 2013 Jun 8;381(9882):2016-23
pubmed: 23746902
Alzheimers Dement. 2014 Jan;10(1):1-9
pubmed: 23871765
Alzheimers Dement. 2014 Jul;10(4):439-447
pubmed: 24418053
Alzheimers Dement. 2015 Mar;11(3):300-9.e2
pubmed: 24613707
Neuroepidemiology. 2014;42(4):197-203
pubmed: 24751796
Int J Geriatr Psychiatry. 2014 Dec;29(12):1212-20
pubmed: 24854229
Alzheimers Dement. 2014 Jun;10(3 Suppl):S122-45
pubmed: 24924665
J Korean Med Sci. 2014 Jul;29(7):903-12
pubmed: 25045221
Biomed Res Int. 2014;2014:908915
pubmed: 25089278
Shanghai Arch Psychiatry. 2014 Feb;26(1):4-14
pubmed: 25114476
Neuroepidemiology. 2014;43(2):114-22
pubmed: 25376362
Dement Geriatr Cogn Disord. 2015;39(5-6):294-302
pubmed: 25792116

Auteurs

Hui Lu (H)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Xiao-Dan Wang (XD)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Zhihong Shi (Z)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Wei Yue (W)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Ying Zhang (Y)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Shuai Liu (S)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Shuling Liu (S)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Lei Zhao (L)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Lei Xiang (L)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Yajing Zhang (Y)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Yalin Guan (Y)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Wenhua Su (W)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Zhiyong Li (Z)

Tianjin Jixian County Health Bureau, Tianjin, China.

Jinhuan Wang (J)

Tianjin Key Laboratory of Cerebrovascular and Neurodegenerative Diseases, Tianjin Huanhu Hospital, Tianjin, China.

Thomas Wisniewski (T)

New York University School of Medicine, Department of Neurology, Psychiatry and Pathology, New York, N.Y., USA.

Yong Ji (Y)

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China. jiyongusa@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH